Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 744

1.

Reasons for discontinuing clozapine: A cohort study of patients commencing treatment.

Legge SE, Hamshere M, Hayes RD, Downs J, O'Donovan MC, Owen MJ, Walters JT, MacCabe JH.

Schizophr Res. 2016 Jul;174(1-3):113-9. doi: 10.1016/j.schres.2016.05.002. Epub 2016 May 19.

2.

Gender differences in CNV burden do not confound schizophrenia CNV associations.

Han J, Walters JT, Kirov G, Pocklington A, Escott-Price V, Owen MJ, Holmans P, O'Donovan MC, Rees E.

Sci Rep. 2016 May 17;6:25986. doi: 10.1038/srep25986.

3.

Parental Origin of Interstitial Duplications at 15q11.2-q13.3 in Schizophrenia and Neurodevelopmental Disorders.

Isles AR, Ingason A, Lowther C, Walters J, Gawlick M, Stöber G, Rees E, Martin J, Little RB, Potter H, Georgieva L, Pizzo L, Ozaki N, Aleksic B, Kushima I, Ikeda M, Iwata N, Levinson DF, Gejman PV, Shi J, Sanders AR, Duan J, Willis J, Sisodiya S, Costain G, Werge TM, Degenhardt F, Giegling I, Rujescu D, Hreidarsson SJ, Saemundsen E, Ahn JW, Ogilvie C, Girirajan SD, Stefansson H, Stefansson K, O'Donovan MC, Owen MJ, Bassett A, Kirov G.

PLoS Genet. 2016 May 6;12(5):e1005993. doi: 10.1371/journal.pgen.1005993. eCollection 2016 May.

4.

Pathogenic copy number variants and SCN1A mutations in patients with intellectual disability and childhood-onset epilepsy.

Fry AE, Rees E, Thompson R, Mantripragada K, Blake P, Jones G, Morgan S, Jose S, Mugalaasi H, Archer H, McCann E, Clarke A, Taylor C, Davies S, Gibbon F, Te Water Naude J, Hartley L, Thomas G, White C, Natarajan J, Thomas RH, Drew C, Chung SK, Rees MI, Holmans P, Owen MJ, Kirov G, Pilz DT, Kerr MP.

BMC Med Genet. 2016 Apr 26;17(1):34. doi: 10.1186/s12881-016-0294-2.

5.

Genome-wide Significant Associations for Cannabis Dependence Severity: Relevance to Psychiatric Disorders.

Walters JT, Owen MJ.

JAMA Psychiatry. 2016 May 1;73(5):443-4. doi: 10.1001/jamapsychiatry.2016.0046. No abstract available.

PMID:
27027914
6.

Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders.

Singh T, Kurki MI, Curtis D, Purcell SM, Crooks L, McRae J, Suvisaari J, Chheda H, Blackwood D, Breen G, Pietiläinen O, Gerety SS, Ayub M, Blyth M, Cole T, Collier D, Coomber EL, Craddock N, Daly MJ, Danesh J, DiForti M, Foster A, Freimer NB, Geschwind D, Johnstone M, Joss S, Kirov G, Körkkö J, Kuismin O, Holmans P, Hultman CM, Iyegbe C, Lönnqvist J, Männikkö M, McCarroll SA, McGuffin P, McIntosh AM, McQuillin A, Moilanen JS, Moore C, Murray RM, Newbury-Ecob R, Ouwehand W, Paunio T, Prigmore E, Rees E, Roberts D, Sambrook J, Sklar P, Clair DS, Veijola J, Walters JT, Williams H; Swedish Schizophrenia Study; INTERVAL Study; DDD Study; UK10 K Consortium, Sullivan PF, Hurles ME, O'Donovan MC, Palotie A, Owen MJ, Barrett JC.

Nat Neurosci. 2016 Apr;19(4):571-7. doi: 10.1038/nn.4267. Epub 2016 Mar 14.

PMID:
26974950
7.

Altering the course of schizophrenia: progress and perspectives.

Millan MJ, Andrieux A, Bartzokis G, Cadenhead K, Dazzan P, Fusar-Poli P, Gallinat J, Giedd J, Grayson DR, Heinrichs M, Kahn R, Krebs MO, Leboyer M, Lewis D, Marin O, Marin P, Meyer-Lindenberg A, McGorry P, McGuire P, Owen MJ, Patterson P, Sawa A, Spedding M, Uhlhaas P, Vaccarino F, Wahlestedt C, Weinberger D.

Nat Rev Drug Discov. 2016 Mar 4. doi: 10.1038/nrd.2016.28. [Epub ahead of print]

PMID:
26939910
8.

What can we learn from the high rates of schizophrenia in people with 22q11.2 deletion syndrome?

Owen MJ, Doherty JL.

World Psychiatry. 2016 Feb;15(1):23-5. doi: 10.1002/wps.20274. No abstract available.

9.

Phenotypic Manifestation of Genetic Risk for Schizophrenia During Adolescence in the General Population.

Jones HJ, Stergiakouli E, Tansey KE, Hubbard L, Heron J, Cannon M, Holmans P, Lewis G, Linden DE, Jones PB, Davey Smith G, O'Donovan MC, Owen MJ, Walters JT, Zammit S.

JAMA Psychiatry. 2016 Mar 1;73(3):221-8. doi: 10.1001/jamapsychiatry.2015.3058.

PMID:
26818099
10.

Psychiatric disorders, myoclonus dystonia and SGCE: an international study.

Peall KJ, Dijk JM, Saunders-Pullman R, Dreissen YE, van Loon I, Cath D, Kurian MA, Owen MJ, Foncke EM, Morris HR, Gasser T, Bressman S, Asmus F, Tijssen MA.

Ann Clin Transl Neurol. 2015 Nov 20;3(1):4-11. doi: 10.1002/acn3.263. eCollection 2016 Jan.

11.

Schizophrenia.

Owen MJ, Sawa A, Mortensen PB.

Lancet. 2016 Jan 14. pii: S0140-6736(15)01121-6. doi: 10.1016/S0140-6736(15)01121-6. [Epub ahead of print] Review.

PMID:
26777917
12.

Exome arrays capture polygenic rare variant contributions to schizophrenia.

Richards AL, Leonenko G, Walters JT, Kavanagh DH, Rees EG, Evans A, Chambert KD, Moran JL, Goldstein J, Neale BM, McCarroll SA, Pocklington AJ, Holmans PA, Owen MJ, O'Donovan MC.

Hum Mol Genet. 2016 Mar 1;25(5):1001-7. doi: 10.1093/hmg/ddv620. Epub 2016 Jan 5.

13.

Alzheimer's disease: the amyloid hypothesis on trial.

Harrison JR, Owen MJ.

Br J Psychiatry. 2016 Jan;208(1):1-3. doi: 10.1192/bjp.bp.115.167569.

PMID:
26729836
14.

Evidence of Common Genetic Overlap Between Schizophrenia and Cognition.

Hubbard L, Tansey KE, Rai D, Jones P, Ripke S, Chambert KD, Moran JL, McCarroll SA, Linden DE, Owen MJ, O'Donovan MC, Walters JT, Zammit S.

Schizophr Bull. 2016 May;42(3):832-42. doi: 10.1093/schbul/sbv168. Epub 2015 Dec 16.

15.

Mental health resilience in the adolescent offspring of parents with depression: a prospective longitudinal study.

Collishaw S, Hammerton G, Mahedy L, Sellers R, Owen MJ, Craddock N, Thapar AK, Harold GT, Rice F, Thapar A.

Lancet Psychiatry. 2016 Jan;3(1):49-57. doi: 10.1016/S2215-0366(15)00358-2. Epub 2015 Dec 2.

16.

Common alleles contribute to schizophrenia in CNV carriers.

Tansey KE, Rees E, Linden DE, Ripke S, Chambert KD, Moran JL, McCarroll SA, Holmans P, Kirov G, Walters J, Owen MJ, O'Donovan MC.

Mol Psychiatry. 2015 Dec 8. doi: 10.1038/mp.2015.170. [Epub ahead of print] No abstract available.

PMID:
26643540
17.

No Evidence for Enrichment in Schizophrenia for Common Allelic Associations at Imprinted Loci.

Escott-Price V, Kirov G, Rees E, Isles AR, Owen MJ, O'Donovan MC.

PLoS One. 2015 Dec 3;10(12):e0144172. doi: 10.1371/journal.pone.0144172. eCollection 2015.

18.

Defining the Effect of the 16p11.2 Duplication on Cognition, Behavior, and Medical Comorbidities.

D'Angelo D, Lebon S, Chen Q, Martin-Brevet S, Snyder LG, Hippolyte L, Hanson E, Maillard AM, Faucett WA, Macé A, Pain A, Bernier R, Chawner SJ, David A, Andrieux J, Aylward E, Baujat G, Caldeira I, Conus P, Ferrari C, Forzano F, Gérard M, Goin-Kochel RP, Grant E, Hunter JV, Isidor B, Jacquette A, Jønch AE, Keren B, Lacombe D, Le Caignec C, Martin CL, Männik K, Metspalu A, Mignot C, Mukherjee P, Owen MJ, Passeggeri M, Rooryck-Thambo C, Rosenfeld JA, Spence SJ, Steinman KJ, Tjernagel J, Van Haelst M, Shen Y, Draganski B, Sherr EH, Ledbetter DH, van den Bree MB, Beckmann JS, Spiro JE, Reymond A, Jacquemont S, Chung WK; Cardiff University Experiences of Children With Copy Number Variants (ECHO) Study; 16p11.2 European Consortium; Simons Variation in Individuals Project (VIP) Consortium.

JAMA Psychiatry. 2016 Jan;73(1):20-30. doi: 10.1001/jamapsychiatry.2015.2123.

PMID:
26629640
19.

Charting the landscape of priority problems in psychiatry, part 1: classification and diagnosis.

Stephan KE, Bach DR, Fletcher PC, Flint J, Frank MJ, Friston KJ, Heinz A, Huys QJ, Owen MJ, Binder EB, Dayan P, Johnstone EC, Meyer-Lindenberg A, Montague PR, Schnyder U, Wang XJ, Breakspear M.

Lancet Psychiatry. 2016 Jan;3(1):77-83. doi: 10.1016/S2215-0366(15)00361-2. Epub 2015 Nov 11. Review.

PMID:
26573970
20.

Charting the landscape of priority problems in psychiatry, part 2: pathogenesis and aetiology.

Stephan KE, Binder EB, Breakspear M, Dayan P, Johnstone EC, Meyer-Lindenberg A, Schnyder U, Wang XJ, Bach DR, Fletcher PC, Flint J, Frank MJ, Heinz A, Huys QJ, Montague PR, Owen MJ, Friston KJ.

Lancet Psychiatry. 2016 Jan;3(1):84-90. doi: 10.1016/S2215-0366(15)00360-0. Epub 2015 Nov 11. Review.

PMID:
26573969
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk